LFLY vs. CCLD, SSY, BIOL, GTBP, OGEN, SISI, DRUG, SNPX, ALZN, and AFIB
Should you be buying Leafly stock or one of its competitors? The main competitors of Leafly include CareCloud (CCLD), SunLink Health Systems (SSY), BIOLASE (BIOL), GT Biopharma (GTBP), Oragenics (OGEN), Shineco (SISI), Bright Minds Biosciences (DRUG), Synaptogenix (SNPX), Alzamend Neuro (ALZN), and Acutus Medical (AFIB). These companies are all part of the "medical" sector.
Leafly (NASDAQ:LFLY) and CareCloud (NASDAQ:CCLD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.
In the previous week, Leafly and Leafly both had 2 articles in the media. CareCloud's average media sentiment score of 0.50 beat Leafly's score of 0.15 indicating that CareCloud is being referred to more favorably in the news media.
Leafly presently has a consensus price target of $6.00, suggesting a potential upside of 189.86%. CareCloud has a consensus price target of $3.17, suggesting a potential upside of 196.03%. Given CareCloud's higher possible upside, analysts plainly believe CareCloud is more favorable than Leafly.
15.6% of Leafly shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 11.3% of Leafly shares are held by insiders. Comparatively, 34.4% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
CareCloud received 2 more outperform votes than Leafly when rated by MarketBeat users. Likewise, 62.50% of users gave CareCloud an outperform vote while only 37.50% of users gave Leafly an outperform vote.
Leafly has higher earnings, but lower revenue than CareCloud. Leafly is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.
Leafly has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, CareCloud has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.
Leafly has a net margin of -22.48% compared to CareCloud's net margin of -41.58%. Leafly's return on equity of 0.00% beat CareCloud's return on equity.
Summary
CareCloud beats Leafly on 11 of the 16 factors compared between the two stocks.
Get Leafly News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFLY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
